期刊文献+

血浆降钙素原和C-反应蛋白在剖宫产后感染中的诊断价值 被引量:5

下载PDF
导出
摘要 目的探讨血浆降钙素原(PCT)和C-反应蛋白(CRP)在剖宫产后感染中的诊断价值。方法对681例剖宫产产妇(其中非细菌感染658例,细菌感染23例),应用酶联免疫荧光分析技术定量检测产后24~48h血浆PCT,并采用免疫比浊法定量检测血浆CRP水平。结果以PCT≥0.05g/L为阳性标准,细菌感染组PCT检测阳性率为95.7%(22/23),非细菌感染组阳性率为0.3%(2/658),两组差异有统计学意义(<0.01);以CRP≥8mg/L为阳性判断,细菌感染组阳性率为91.3%(21/23),非感染组为87.8%(578/658),两组差异无统计学意义(>0.05)。结论剖宫产后24~48h血浆PCT对早期产后感染的诊断优于CRP。
出处 《现代实用医学》 2010年第4期396-397,共2页 Modern Practical Medicine
  • 相关文献

参考文献7

  • 1杨滨,康梅.降钙素原在细菌感染性疾病诊断及治疗中的应用[J].现代预防医学,2009,36(3):596-597. 被引量:111
  • 2Arkader R,Troster EJ.Procalcitonin doesdiscriminate between sepsis and systemic inflmmnatory response syndrome[J].Archivcs of Disease in Childhood 2006,91(2):117-120.
  • 3Castelli GP,Pognani C,Cita M,et al.Procitonin,C-reactive protein,white blood cells and SOFA score in ICU diagnosis and monitoring of sepsis[J].Minerua Anestesiol,2006.72(1):69-80.
  • 4Schneid-Kofman N,Sheninera E,Lovvb TA.Risk factors for ound infection following cesarean deliveries[J].Intern Gynecol Obset,2005,90(1):10-15.
  • 5Myles TD,Gooch J,Santolaya J.Obesity as an independent risk factor for infectious morbidity in patients who undergo cesarean delivery[J].Obstot Gynecol,2002,100(5):959-964.
  • 6Killian CA,Graffunder EM,Vinciguerra TJ.et al.Risk factors fo rsurgical-site infections following cesarean section[J].Infect Control Hospital Epidemio,2001,22(10):613-617.
  • 7吴少卿,文道林,曹文平.血清降钙素原和C-反应蛋白在细菌感染性疾病诊断中的意义[J].中国现代医药杂志,2009,11(4):66-68. 被引量:54

二级参考文献16

  • 1简序,王金和,程佩兰.C反应蛋白的临床研究进展[J].国际检验医学杂志,2004,26(5):471-473. 被引量:137
  • 2崔晓明.C-反应蛋白测定对小儿急性上呼吸道感染的临床价值[J].实用诊断与治疗杂志,2004,18(5):383-384. 被引量:26
  • 3俞娅芬,陈德昌,宋秀琴.早期诊断严重脓毒症 脓毒性休克研究进展[J].中国急救医学,2007,27(2):154-156. 被引量:56
  • 4Mirjam Christ-Crain, Beat Miiller. Procalcitonin in bacterial infections-hype, hope, more or less [J]? Swiss Med Wkly, 2005, 135: 451--460.
  • 5Muller B, White JC, Nylen E, et al. Ubiquitous expression of the ealcitortin-1 gene in multiple tissues in response to sepsis [J]. J Clin Endocrinol Metab, 2001, 86: 396-404.
  • 6Philippe Linseheid, Dalma Seboek, Eric S. Nylen, et al. In Vitro and in Vivo Caleitonin I Gene Expression in Parenchymal Cells: A Novel Product of Human Adipose Tissue [J]. Endocrinology, 2003, 144: 5578-5584.
  • 7Meisner M., Procalcitonin (PCT) A new, innovative infection parameter.; Biochemical and clinical aspects; ISBN: 3-13- 105503-0 [S]. Thieme Stuttgart, New York, 2000.
  • 8Mirjam Christ-Crain, Dalana Stolz, Roland Bingisser, et al. Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia [J]. American journal of respiratory and critical care medicine, 2006, 174: 84-93.
  • 9Daiana Stolz, Miriam Christ-Crain, Roland Bingisser, et al. Antibiotic Treatment of Exacerbations of COPD [J]. Chest, 2007, 1 : 9-19.
  • 10Christ-Crain M, Jaccard-Stolz D, Bingisser R, et al. Effect of procalcitanin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial [J]. Lancet, 2004, 363: 600-607.

共引文献161

同被引文献38

  • 1任占宝,王金英,李晓阳,宋建梅.降钙素原在鉴别呼吸道感染时的临床意义[J].继续医学教育,2012,26(1):61-63. 被引量:3
  • 2Dimitriu G. Contribution to improve the effectiveness of preventive interventions in order to reduce the risk of endomyoparametritis and surgical wound infections [J] . Rev Med Chit Soc Med Nat lasi, 2010, 114 (2) :457-459.
  • 3Claeys R, Vinken S, Spapen H, et al. Plasma proalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med, 2002,30.. 757-762.
  • 4Ortqvist A, Hedlund J, Wretlind B, et al. Diagnostic and prognostic value of interleukin-6 and C-reactive protein in community acquired pneumonia. Scand J Infect Dis, 1995, 27 (5) : 457-462.
  • 5张代民.降钙素原的测定与临床应用进展[J].实用医药杂志,2007,24(5):619-622. 被引量:57
  • 6Remskar M, Horvat M, Hojker S, et al. Procalcitonin in patients with acute myocardial infarction [ J ]. Wienklin Wcchenschr, 2012,141 ( 5 ) :205-210.
  • 7Taniguchi T, Kidani Y, Kanakura H, et al. Procalcitonin in acute myocardial infarction [ J]. Crit Care Med, 2007,32 (5) : 1322- 1326.
  • 8Urban MK, Wukovits B, Flynn E. Procalcitonin increase in early identification of critically ill patients at high risk of mortality [ J ]. Crit Care Med, 2009,101 (3) : 158-159.
  • 9Boyer J, Muller B. Physiology and genetics of procalcitonin [ J ]. Physiol Res, 2009,28 (3) : 102-109.
  • 10Yu ZB, Liu J, Qiu Y, et al. The accuracy of the procalcitonin test for the diagnosis of neonatal sepsis: a meta-analysis [ J ]. Scand J Infect Dis, 2010,42 ( 11 ) :723-733.

引证文献5

二级引证文献53

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部